Compounds > 7-(n-(3-aminopropyl)amino)heptan-2-one
Page last updated: 2024-09-03

7-(n-(3-aminopropyl)amino)heptan-2-one and kanamycin a

7-(n-(3-aminopropyl)amino)heptan-2-one has been researched along with kanamycin a in 1 studies

Compound Research Comparison

Studies
(7-(n-(3-aminopropyl)amino)heptan-2-one)		Trials
(7-(n-(3-aminopropyl)amino)heptan-2-one)		Recent Studies (post-2010)
(7-(n-(3-aminopropyl)amino)heptan-2-one)		Studies
(kanamycin a)		Trials
(kanamycin a)		Recent Studies (post-2010) (kanamycin a)
7027,169187946

Protein Interaction Comparison

ProteinTaxonomy7-(n-(3-aminopropyl)amino)heptan-2-one (IC50)kanamycin a (IC50)
3-oxoacyl-[acyl-carrier-protein] synthase 3Escherichia coli K-126.8
Gap junction beta-2 proteinHomo sapiens (human)9.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, T; Ji, X; Li, W; Yu, R; Zhang, C; Zhou, L; Zhu, M1

Other Studies

1 other study(ies) available for 7-(n-(3-aminopropyl)amino)heptan-2-one and kanamycin a

ArticleYear
Diadenosine tetraphosphate modulated quorum sensing in bacteria treated with kanamycin.
    BMC microbiology, 2023, Nov-17, Volume: 23, Issue:1

    Topics: Escherichia coli; Kanamycin; Quorum Sensing

2023